Le Lézard
Classified in: Health
Subject: HEALTH

Marijuana Victims' Association: Is Marijuana the New Thalidomide


VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 4, 2016) - Phocomelia (limb malformation) has been shown in testing(i) of THC marijuana in a similar preclinical model to that which revealed the teratogenicity of thalidomide.

The federal government is aware of serious marijuana harms; it must not be complicit in risking Canadian health, but must mitigate by placing marijuana products under a protective protocol similar to REVAID used for Thalidomide.

As the stewards of the country's human and financial resources, it is critical that government protect the public from potential irreversible harm and itself from litigation. Marijuana harm is not only possible but probable.

A Health Canada document cites 1,000 scientific references that substantiate the risks.

The June 2016 Government public consultation discussion paper fails to inform the public of the risks, specifically to the fetus and reproduction by males.

If thalidomide offered the "high" of pot would it be reasonable to legalizing it for recreational use?

(i)Ref: Reece AS, Hulse GK. Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity. Mutat Res. 2016;789:15-25.

Contact Information:
Marijuana Victims' Association
Pamela McColl
SAM Canada
1-778 354 3551

These press releases may also interest you

at 07:35
Frequency Therapeutics, Inc. , a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced the completion of enrollment of its...

at 07:35
QuestCap Inc. ("QuestCap" or the "Company") through its wholly-owned subsidiary, Collection Sites, LLC is working with Art Angels Gallery, Los Angeles, California to launch COVID-19 testing protocols to help safely return art exhibitions for artists...

at 07:35
Auxly Cannabis Group Inc.  ("Auxly" or the "Company"), a consumer packaged goods company in the cannabis products market, is thrilled to announce that its wholly owned subsidiary, KGK Science Inc. ("KGK") has received its second Cannabis Research...

at 07:30
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") , a leader in full-service, therapeutic antibody discovery and development, today announced that its subsidiary, IPA Europe, has made a substantial investment in its B-Cell Selecttm platform at...

at 07:30
InMed Pharmaceuticals Inc. ("InMed" or the "Company") , a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol ("CBN"), today...

at 07:30
Codagenix, Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, today announced that the Serum Institute of India has begun manufacturing CDX-005, the company's intranasal, live-attenuated...



News published on 4 august 2016 at 10:03 and distributed by: